December 21, 2023 – Page 7

SELLAS Receives FDA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas

Written by Customer Service on December 21, 2023. Posted in Public Companies.

– SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); ORR in r/r PTCL Patients with Standard of Care is 25.8% – – One Patient with Complete Metabolic Response Continuing Treatment for over 62 weeks and another patient with Complete Response by CT Continuing Treatment for over 24 weeks – – Phase 1b/2 Study in PTCL Ongoing with top line data expected in 1H 2024 – NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD)...

NFT Gaming Company Launches Artificial Intelligence (AI) Game, Jigsaw Puzzle AI, on Apple and Google Play

Written by Customer Service on December 21, 2023. Posted in Public Companies.

The Company’s fourth release for Gaxos, its blockchain gaming platform Roseland, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) — The NFT Gaming Company, Inc. (“NFTG” or the “Company”), a company developing a digital gaming platform and community that will offer users the ability to create unique avatars playable in all of the games on the platform in the form of non-fungible tokens, or “NFTs,” today announced that the company has launched its fourth game, Jigsaw Puzzle AI for Android and iOS. The game is available to download in the Google Play Store and Apple App Store. To download the game, click here: Jigsaw Puzzle AI “The NFT Gaming Company is extremely pleased to launch our fourth game as we continue to release our suite of games for Gaxos,” said Vadim Mats, CEO of NFT Gaming Company. “Every game is a step toward...

Snail., Inc Unveils Everlasting Winter Wonderland Mod For ARK: Survival Ascended

Written by Customer Service on December 21, 2023. Posted in Public Companies.

Transforming the Land of Dinosaurs into a Winter Wonderland will begin on December 21, 2023, joining the already approved 600+ mods currently available. CULVER CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment is thrilled to announce a festive transformation in ARK: Survival Ascended as the highly anticipated Winter Wonderland event becomes a permanent fixture as a mod. Beginning today, Survivors across all platforms, including console players, will be able to immerse themselves in the enchanting Winter Wonderland and experience the magic of the season anytime throughout the year. New Winter Wonderland Creatures: Prepare for a host of new creatures to roam the Winter Wonderland landscape,...

Microbix Reports Results for Q4 & Full-Year Fiscal 2023

Written by Customer Service on December 21, 2023. Posted in Earnings Releases And Operating Results.

Full-Year Sales of $16.5 million and Net Loss of $0.04 million MISSISSAUGA, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2023 (“2023” & “Q4”), with solid sales and a resumption of profitability in Q4, ongoing progress to increase revenues from its diagnostic-test related ingredients and devices, and recognition of a fully-funded program to revalidate and relaunch its approved drug, Kinlytic® urokinase. Management DiscussionResults for Q4 and 2023 complete a challenging and fulfilling year during which Microbix successfully adapted to post-pandemic conditions – adding important new customers and products, signing a fully-funded redevelopment deal...

Form 8.3 – [YOUNG & CO.’S BREWERY PLC 20 12 2023] – (CGWL)

Written by Customer Service on December 21, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree YOUNG & CO.’S BREWERY PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date...

Year End Review & 2024 Outlook, Management Changes and 2023 Incentive Awards

Written by Customer Service on December 21, 2023. Posted in Public Companies.

Map of Region Map of Region TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSX-V: SEI, OTCQB: SEUSF) (“Sintana” or the “Company”) is pleased to provide the following 2023 Review and 2024 Outlook, an update on management and a summary of incentive awards approved at the Company’s annual general meeting. “Building off of our Namibia entry in 2022, 2023 was another year of significant progress for Sintana,” said Robert Bose, President and Director. “The continuing emergence of Namibia’s Orange Basin and the significant progress on both our licenses and on the adjacent blocks, continue to demonstrate the size and scale of the opportunity, the unmatched quality of our portfolio and the timeliness of our entry. Multiple catalysts in the near-term position the Company and its shareholders for success in 2024,” he...

Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA

Written by Customer Service on December 21, 2023. Posted in Public Companies.

Written Preliminary Comments on the Phase 3 Registration Trial for MAT2203 Move Company Closer to Full Alignment with FDA Matinas to Meet with FDA Early in the First Quarter of 2024 to Finalize Phase 3 Study Design Partnership Discussions Remain Ongoing for MAT2203 BEDMINSTER, N.J., Dec. 21, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform technology, announces receipt of written feedback from U.S. Food and Drug Administration (FDA) on its proposed revised protocol for a Phase 3 study of MAT2203 in patients with invasive aspergillosis with limited or no treatment options. The preliminary written comments move the Company closer to alignment with FDA on the design of...

Revival Gold Annual Stock Option Grant

Written by Customer Service on December 21, 2023. Posted in Public Companies.

TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), announces that pursuant to the Company’s stock option plan, Revival Gold has granted 1,855,000 incentive stock options (the “Options”) to directors, officers, and consultants of the Company as part of its annual compensation plan. The Options are exercisable at a price of $0.50 per share for a period of five years and are subject to vesting provisions. About Revival Gold Inc. Revival Gold is a growth-focused gold exploration and development company. The Company is advancing the Beartrack-Arnett Gold Project located in Idaho, USA. Beartrack-Arnett is the largest past-producing gold mine in Idaho. The Project benefits from extensive existing infrastructure and is the subject of a recent Preliminary Feasibility...

Pacira Appoints Frank D. Lee as Chief Executive Officer

Written by Customer Service on December 21, 2023. Posted in Public Companies.

— Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization — — Paul J. Hastings Named Chair of the Board — — Dave Stack to Remain in Advisory Role through August 2025 — TAMPA, Fla., Dec. 21, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that its Board of Directors (the “Board”) has appointed Frank D. Lee as Chief Executive Officer and a member of the Board, effective January 2, 2024. As previously announced in September 2023, David Stack will retire from his roles as Chief Executive Officer and Chairman of the Board, effective January 1, 2024, and will remain with the company...

nCino and Salesforce Expand Strategic Partnership to Further Modernize the Financial Services Industry

Written by Customer Service on December 21, 2023. Posted in Public Companies.

Leaders in cloud innovation reinforce alliance to provide best-in-class solutions to the financial services industry by extending successful partnership to 2031 Updated commercial terms expected to improve nCino’s subscription gross margins WILMINGTON, N.C., Dec. 21, 2023 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced an expanded partnership with Salesforce to accelerate the delivery of best-in-class cloud solutions to the financial services industry. This builds on nCino and Salesforce’s long-standing collaboration, established in 2011, to empower financial institutions with digital innovations that increase efficiency, transparency, and reduce risks while driving customer growth and loyalty. “Our strategic partnership with Salesforce has enabled...

Day: December 21, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice